[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals (REGN) sees stock price surge, driven by positive sentiment around Dupixent sales and trial results, alongside notable investor activity, despite some concerns.

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious medical conditions.
Regeneron Pharmaceuticals Inc uses the ticker $REGN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Regeneron Pharmaceuticals Inc (REGN) social dominance is up XXXXXX% from the previous X months.
Regeneron Pharmaceuticals Inc (REGN) creators is up XXXXX% from the previous week.

Price: $XXX

Price 24-Hour Time-Series Raw Data
The stock price is up today, likely fueled by positive social sentiment around Dupixent sales growth and recent trial results, as well as Michael Burry's investment, offsetting concerns about stake reductions and data privacy issues.

24-Hour: -XXXX% 7-Day: XXXX% 30-Day: XXXX%

1-Year High: $XXXXXX on 2025-11-25
1-Year Low: $XXXXXX on 2025-06-05

AltRank: XXX

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Regeneron Pharmaceuticals Inc (REGN) is currently AltRank #249 based on combined combined social and market metrics Daily Average: XXX
X Week: XXX -XX
X Month: XXX +23
X Months: XXX +103
X Year: XXX +97
1-Year High: XXXXX on 2025-07-04
1-Year Low: X on 2025-01-11

Galaxy Score: XXXXX

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +5
X Month: XX -XX
X Months: XX +18
X Year: XX +27
1-Year High: XX on 2025-10-01
1-Year Low: XX on 2025-07-19

Engagements: XXXXXX (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXXX +106%
1-Year High: XXXXXXXXX on 2025-02-04
1-Year Low: XXXXX on 2025-04-05

Engagements by network (24h): Reddit: XX X: XXXXXX

Mentions: XXX (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXXXX -XXXX%
X Months: XXXXXX +25%
X Year: XXXXXX +65%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-12-07

Mentions by network (24h): Reddit: XX X: XXXXX

Creators: XXX (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Regeneron Pharmaceuticals Inc (REGN) in the last XX hours which is down XX% from XXX in the previous XX hours Daily Average: XXX
X Week: XXX +11%
X Month: XXX -X%
X Months: XXXXX +112%
X Year: XXXXX +151%
1-Year High: XXX on 2025-06-27
1-Year Low: XX on 2025-01-27

The most influential creators that mention Regeneron Pharmaceuticals Inc in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@HOThomasWPhelps	X	XXXXX	X	XXXXX
@hfphila	X	XXXXX	X	XXX
@nataninvesting	X	XXXXXX	X	XXX
@doepke_michel	X	XXXXX	X	XXX
@schaeffers	X	XXXXXX	X	XXX
@Bart_Bartko	X	XXXXX	X	XXX
@semodough	X	XXXXXX	X	XXX
@Quantumup1	X	XXXXX	X	XXX
@finsquawk_	X	XXX	X	XXX
@bn_trader	XX	XXXXX	X	XXX

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% -XX%
X Months: XX% +4%
X Year: XX% -X%
1-Year High: XX% on 2025-07-06
1-Year Low: XX% on 2025-03-06

Most Supportive Themes:

Dupixent Sales Growth: (50%) Social media is highlighting strong Dupixent sales growth, particularly with the launch for COPD, indicating strong potential for the company.
Pipeline Optimism: (30%) Analysts and investors express optimism about Regeneron's pipeline and potential for future growth.
Positive Technical Indicators: (13%) Several posts highlight positive technical indicators and potential for price increases.

Most Critical Themes:

Stake Reduction and Data Privacy Concerns: (6%) Investors are expressing concerns about stake reduction and data privacy issues and the stock's underperformance.

Social Dominance: XXXXX%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.011%
X Month: XXXXX% +0.038%
X Months: XXXXX% +0.0023%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-02-04
1-Year Low: XXXXX% on 2025-12-06

Market Dominance: XXXX%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXX%
Daily Average: X%
1-Year High: X% on 2025-03-10
1-Year Low: XXXX% on 2025-12-12

Market Cap: $XXXXXXXXXXXXXX

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXXX +$2.20%
X Month: $XXXXXXXXXXXXXX +$8%
X Months: $XXXXXXXXXXXXXX +$35%
X Year: $XXXXXXXXXXXXXX -$3.20%
1-Year High: $XXXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXXX on 2025-06-05